Epilepsy Surgery in 2019 : A Time to Change
Authors:
Open Access
- 1 May 2019
- journal article
- review article
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 62 (3) , 361-365
Abstract
Epilepsy has been known to humankind since antiquity. The surgical treatment of epilepsy began in the early days of neurosurgery and has developed greatly. Many surgical procedures have stood the test of time. However, clinicians treating epilepsy patients are now witnessing a huge tide of change. In 2017, the classification system for seizure and epilepsy types was revised nearly 36 years after the previous scheme was released. The actual difference between these systems may not be large, but there have been many conceptual changes, and clinicians must bid farewell to old terminology. Paradigms in drug discovery are changing, and novel antiseizure drugs have been introduced for clinical use. In particular, drugs that target genetic changes harbor greater therapeutic potential than previous screening-based compounds. The concept of focal epilepsy has been challenged, and now epilepsy is regarded as a network disorder. With this novel concept, stereotactic electroencephalography (SEEG) is becoming increasingly popular for the evaluation of dysfunctioning neuronal networks. Minimally invasive ablative therapies using SEEG electrodes and neuromodulatory therapies such as deep brain stimulation and vagus nerve stimulation are widely applied to remedy dysfunctional epilepsy networks. The use of responsive neurostimulation is currently off-label in children with intractable epilepsy.Keywords
Funding Information
- National Research Foundation of Korea (2018R1D1A1A 02086005)
This publication has 35 references indexed in Scilit:
- Obsessive–compulsive disorder in chronic epilepsyEpilepsy & Behavior, 2011
- The association between depression and epilepsy in a nationally representative sampleEpilepsia, 2009
- Epilepsy Surgery: Historical Highlights 1909–2009Epilepsia, 2009
- Clinical neurophysiology with special reference to the electroencephalogramEpilepsia, 2009
- Levetiracetam: the first SV2A ligand for the treatment of epilepsyExpert Opinion on Drug Discovery, 2007
- A Randomized, Controlled Trial of Surgery for Temporal-Lobe EpilepsyNew England Journal of Medicine, 2001
- A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizuresNeurology, 1995
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981
- LOSS OF RECENT MEMORY AFTER BILATERAL HIPPOCAMPAL LESIONSJournal of Neurology, Neurosurgery & Psychiatry, 1957